In the early tumor stages, TGF-β behaves as a tumor suppressor by inhibiting proliferation of epithelial cells through regulation of the expression of c-Myc and cyclin-dependent kinase inhibitors, and by inducing apoptosis11, 12. The gene discussed is TGFB1; the disease is neoplasm.